Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old

被引:219
|
作者
Raghu, Ganesh [1 ]
Chen, Shih-Yin [2 ]
Hou, Qiang [2 ]
Yeh, Wei-Shi [2 ]
Collard, Harold R. [3 ]
机构
[1] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA
[2] Biogen, Hlth Econ & Outcomes Res, Cambridge, MA USA
[3] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA
关键词
AGED; 65; YEARS; CLINICAL-COURSE; UNITED-STATES; SURVIVAL; MANAGEMENT; DIAGNOSIS; MORTALITY;
D O I
10.1183/13993003.01653-2015
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We sought to present the epidemiology of idiopathic pulmonary fibrosis (IPF) in adults 18-64 years old in the USA. From adults aged 18-64 years in a large administrative claims data in 2004-2010, patients with IPF were identified using diagnosis codes. We estimated annual incidence and cumulative prevalence of IPF over time, and examined potential risk factors for the IPF diagnosis. The annual cumulative prevalence increased steadily in the first few years (from 13.4 cases per 100 000 persons in 2005 to 18.2 cases in 2010 per 100 000 persons), which is likely due to a methodological reason, while the annual incidence of IPF decreased over time (from 7.9 cases per 100 000 person-years in 2005 to 5.8 cases in 2010 per 100 000 person-years). The overall decrease was mainly driven by a decreasing trend in the younger patients (aged 18-44 years), while the incidence in older patients remained stable. Consistent trends were observed in subgroups defined by previously published more restrictive algorithms for diagnosis. Older age and male sex were associated with a higher incidence of disease (p<0.05). In US adults younger than 65 years, we observed a decreasing incidence of IPF over time which may partially explain the plateau of cumulative prevalence in the last few years of our data.
引用
收藏
页码:179 / 186
页数:8
相关论文
共 50 条
  • [31] National Trends in Out-of-Pocket Costs Among US Adults With Diabetes Aged 18-64 Years: 2001-2017
    Wang, Yu
    Park, Joohyun
    Li, Rui
    Luman, Elizabeth
    Zhang, Ping
    DIABETES CARE, 2021, 44 (11) : 2510 - 2517
  • [32] Epidemiology, survival, incidence and prevalence of idiopathic pulmonary fibrosis in the USA and Canada
    Raghu, Ganesh
    EUROPEAN RESPIRATORY JOURNAL, 2017, 49 (01)
  • [33] COVID-19 vaccine hesitancy January-May 2021 among 18-64 year old US adults by employment and occupation
    King, Wendy C.
    Rubinstein, Max
    Reinhart, Alex
    Mejia, Robin
    PREVENTIVE MEDICINE REPORTS, 2021, 24
  • [34] The dietary role of unprocessed beef & lamb in a representative sample of adults aged 18-64 years in Ireland
    O'Sullivan, E.
    Kehoe, L.
    Cocking, C.
    McNulty, B. A.
    Nugent, A. P.
    Cashman, K.
    Walton, J.
    Flynn, A.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2021, 80 (OCE5)
  • [35] Indirect effects of emotion regulation in the relationship between pain and cannabis use in adults 18-64 years
    Schepis, Ty S.
    Rogers, Andrew H.
    Munoz, Liliana
    Zvolensky, Michael J.
    ADDICTIVE BEHAVIORS, 2024, 153
  • [36] Optimal messaging of the Canadian 24-Hour Movement Guidelines for Adults aged 18-64 years and Adults aged 65 years and older
    Faught, Emma
    Walters, Alexandra J.
    Latimer-Cheung, Amy E.
    Faulkner, Guy
    Jones, Rebecca
    Duggan, Mary
    Chulak-Bozzer, Tala
    Lane, Kirstin N.
    Brouwers, Melissa C.
    Tomasone, Jennifer R.
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2020, 45 (10) : S125 - S150
  • [37] Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013
    Weycker, Derek
    Hansen, Gary L.
    Seifer, Frederic D.
    CHRONIC RESPIRATORY DISEASE, 2017, 14 (04) : 377 - 384
  • [38] Suicidal ideation, suicide attempt, and occupations among employed adults aged 18-64 years in the United States
    Han, Beth
    Crosby, Alex E.
    Ortega, LaVonne A. G.
    Parks, Sharyn E.
    Compton, Wilson M.
    Gfroerer, Joseph
    COMPREHENSIVE PSYCHIATRY, 2016, 66 : 176 - 186
  • [39] Characterization of US adults aged 18-64 years vaccinated against mpox within the food and drug administration biologics effectiveness and safety (BEST) initiative
    Gruber, Joann F.
    Matuska, Kathryn
    Wang, Jing
    Clarke, Tainya C.
    McMahill-Walraven, Cheryl N.
    Lloyd, Patricia C.
    Peetluk, Lauren S.
    Secora, Alex
    Hu, Mao
    Song, Jennifer
    Beachler, Daniel C.
    Chillarige, Yoganand
    Wong, Hui-Lee
    Tarazi, Wafa
    Djibo, Djeneba Audrey
    Forshee, Richard A.
    Anderson, Steven A.
    Shoaibi, Azadeh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 149 - 150
  • [40] Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age
    Gorse, Geoffrey J.
    Falsey, Ann R.
    Fling, John A.
    Poling, Terry L.
    Strout, Cynthia B.
    Tsang, Peter H.
    VACCINE, 2013, 31 (19) : 2358 - 2365